<SEC-DOCUMENT>0001415889-23-004744.txt : 20230313
<SEC-HEADER>0001415889-23-004744.hdr.sgml : 20230313
<ACCEPTANCE-DATETIME>20230313160838
ACCESSION NUMBER:		0001415889-23-004744
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20230310
FILED AS OF DATE:		20230313
DATE AS OF CHANGE:		20230313

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Simmons Jeffrey N
		CENTRAL INDEX KEY:			0001479079

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38661
		FILM NUMBER:		23727367

	MAIL ADDRESS:	
		STREET 1:		2500 INNOVATION WAY
		CITY:			GREENFIELD
		STATE:			IN
		ZIP:			46140

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Elanco Animal Health Inc
		CENTRAL INDEX KEY:			0001739104
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				825497352
		FISCAL YEAR END:			1231

	BUSINESS ADDRESS:	
		STREET 1:		2500 INNOVATION WAY
		CITY:			GREENFIELD
		STATE:			IN
		ZIP:			46140
		BUSINESS PHONE:		877-352-6261

	MAIL ADDRESS:	
		STREET 1:		2500 INNOVATION WAY
		CITY:			GREENFIELD
		STATE:			IN
		ZIP:			46140
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>form4-03132023_080325.xml
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0306</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2023-03-10</periodOfReport>

    <issuer>
        <issuerCik>0001739104</issuerCik>
        <issuerName>Elanco Animal Health Inc</issuerName>
        <issuerTradingSymbol>ELAN</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001479079</rptOwnerCik>
            <rptOwnerName>Simmons Jeffrey N</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O ELANCO ANIMAL HEALTH INCORPORATED</rptOwnerStreet1>
            <rptOwnerStreet2>2500 INNOVATION WAY</rptOwnerStreet2>
            <rptOwnerCity>GREENFIELD</rptOwnerCity>
            <rptOwnerState>IN</rptOwnerState>
            <rptOwnerZipCode>46140</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
            <isOfficer>true</isOfficer>
            <isTenPercentOwner>false</isTenPercentOwner>
            <isOther>false</isOther>
            <officerTitle>PRESIDENT, CEO AND DIRECTOR</officerTitle>
            <otherText></otherText>
        </reportingOwnerRelationship>
    </reportingOwner>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <transactionDate>
                <value>2023-03-10</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>P</transactionCode>
                <equitySwapInvolved>0</equitySwapInvolved>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>15000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>9.5981</value>
                    <footnoteId id="F1"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>A</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>45000</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>I</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value>Revocable Trust</value>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
        <nonDerivativeHolding>
            <securityTitle>
                <value>Common Stock</value>
            </securityTitle>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>1142569</value>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
                <natureOfOwnership>
                    <value></value>
                </natureOfOwnership>
            </ownershipNature>
        </nonDerivativeHolding>
    </nonDerivativeTable>

    <derivativeTable></derivativeTable>

    <footnotes>
        <footnote id="F1">Reflects the weighted average price of 15,000 shares of common stock of Elanco Anima Health Inc. purchased by the reporting person in multiple transactions on March 10, 2023 with purchase prices ranging from $9.585 to $9.5999 per share. The reporting person undertakes to provide upon request by the U.S. Securities and Exchange Commission staff, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.</footnote>
    </footnotes>

    <ownerSignature>
        <signatureName>/s/ Catherine S. Powell, as Attorney-in-Fact for Jeffrey N. Simmons</signatureName>
        <signatureDate>2023-03-13</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
